Bill Humphries
Chief Executive Officer
Bill Humphries has served as the Chief Executive Officer of MedPharm since January 2025. Previously, Mr. Humphries led Alcami Corporation, a contract development and manufacturing organization, serving as its Chief Executive Officer and member of its board of directors from June 2023 to January 2025. From May 2021 to May 2023, Mr. Humphries served as the Chief Executive Officer of Isosceles Pharmaceuticals Inc., a biotechnology company. From 2018 to December 2020, Mr. Humphries served as President of Ortho Dermatologics, the dermatology division of Bausch Health Companies, Inc., and previously served as its Executive Vice President, Company Group Chairman for Dermatology and OraPharma from 2017 to 2018. From 2012 to 2016, he served as President and Chief Executive Officer of the North American business of Merz, Inc., an affiliate of Merz Pharma Group, a specialty healthcare company.
From 2006 to 2012, Mr. Humphries served in several leadership positions with Stiefel Laboratories, Inc., a dermatology pharmaceutical company, including its Chief Commercial Officer and then President, beginning in 2008. Stiefel was acquired by GSK in 2009, after which Mr. Humphries served as the President of Dermatology for Stiefel from 2009 until 2012.
Mr. Humphries previously held multiple senior executive roles in sales and marketing, business development, and international marketing for Allergan, Inc., concluding as Vice President of its US skincare business. Mr. Humphries currently serves as a director of the publicly held companies Clearside Biomedical, Inc. and Aclaris Therapeutics. He previously served as a member of the board of directors of PhaseBio Pharmaceuticals, Inc., STRATA Skin Sciences, Inc., and SKNV and Bryn Pharmaceuticals. He received a Bachelor of Arts degree from Bucknell University and a Master of Business Administration from Pepperdine University.
